Vol 31, No 1 (2024)
Research Letter
Published online: 2024-01-22
Percutaneous transaxillary approach for balloon aortic valvuloplasty and complex percutaneous coronary intervention with Impella support
12
, 1, 1, 1, 1
, 1, 1, 1, 1
Abstract
Not available
References
- Diaz Quintero L, Gajo E, Guerrero M, et al. Balloon aortic valvuloplasty followed by impella®-assisted left main coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2021; 22: 16–21.
- Singh V, Yadav PK, Eng MH, et al. Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry. Int J Cardiol. 2017; 240: 120–125.
- Leick J, Werner N, Mangner N, et al. Optimized patient selection in high-risk protected percutaneous coronary intervention. Eur Heart J Suppl. 2022; 24(Suppl J): J4–JJ10.
- Giordano A, Schaefer A, Bhadra OD, et al. Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. Panminerva Med. 2022; 64(4): 427–437.
- Sacha J, Krawczyk K, Gwóźdź W, et al. Fully percutaneous transaxillary aortic valve replacement with effective bailout plan for vascular complications. JACC Cardiovasc Interv. 2020; 13(23): 2811–2812.
- Sacha J, Krawczyk K, Brzeziński Z, et al. Simple method how to avoid stenting in complicated percutaneous transaxillary access. JACC Cardiovasc Interv. 2022; 15(18): e201–e202.
- Patterson T, Clayton T, Dodd M, et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial. JACC Cardiovasc Interv. 2021; 14(18): 1965–1974.
- Flaherty MP, Moses JW, Westenfeld R, et al. Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study. Catheter Cardiovasc Interv. 2020; 95(6): 1111–1121.
- Généreux P, Piazza N, Alu MC, et al. VARC-3 WRITING COMMITTEE. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021; 42(19): 1825–1857.
- Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011; 123(23): 2736–2747.
